Accumulation of human full-length tau induces degradation of nicotinic acetylcholine receptor α4 via activating calpain-2

[1]  Liwang Liu,et al.  Habenula cholinergic neurons regulate anxiety during nicotine withdrawal via nicotinic acetylcholine receptors , 2016, Neuropharmacology.

[2]  I. Skaliora,et al.  High-Affinity Nicotinic Receptors Modulate Spontaneous Cortical Up States In Vitro , 2015, The Journal of Neuroscience.

[3]  Chengbiao Lu,et al.  Contribution of α4β2 nAChR in nicotine-induced intracellular calcium response and excitability of MSDB neurons , 2014, Brain Research.

[4]  M. Baudry,et al.  Distinct Roles for μ-Calpain and m-Calpain in Synaptic NMDAR-Mediated Neuroprotection and Extrasynaptic NMDAR-Mediated Neurodegeneration , 2013, The Journal of Neuroscience.

[5]  B. Hyman,et al.  Tau Causes Synapse Loss without Disrupting Calcium Homeostasis in the rTg4510 Model of Tauopathy , 2013, PloS one.

[6]  J. Yakel,et al.  Effects of neuronal nicotinic acetylcholine receptor allosteric modulators in animal behavior studies. , 2013, Biochemical pharmacology.

[7]  Shanshan Song,et al.  Irregular Ca2+ Oscillations Regulate Transcription via Cumulative Spike Duration and Spike Amplitude* , 2012, The Journal of Biological Chemistry.

[8]  F. LaFerla,et al.  Calpain inhibitor A-705253 mitigates Alzheimer's disease-like pathology and cognitive decline in aged 3xTgAD mice. , 2012, The American journal of pathology.

[9]  Grace E. Stutzmann,et al.  Early calcium dysregulation in Alzheimer’s disease: setting the stage for synaptic dysfunction , 2011, Science China Life Sciences.

[10]  E. Mandelkow,et al.  Cleavage of Tau by calpain in Alzheimer's disease: the quest for the toxic 17 kD fragment , 2011, Neurobiology of Aging.

[11]  R. Hayes,et al.  Dual vulnerability of tau to calpains and caspase-3 proteolysis under neurotoxic and neurodegenerative conditions , 2010, ASN neuro.

[12]  Jian-Zhi Wang,et al.  Proteasome inhibition increases tau accumulation independent of phosphorylation , 2009, Neurobiology of Aging.

[13]  Tsuyoshi Miyakawa,et al.  Dissection of Hippocampal Dentate Gyrus from Adult Mouse , 2009, Journal of visualized experiments : JoVE.

[14]  J. Buccafusco,et al.  A reversible model of the cognitive impairment associated with schizophrenia in monkeys: potential therapeutic effects of two nicotinic acetylcholine receptor agonists. , 2009, Biochemical pharmacology.

[15]  C. Sindic,et al.  Expression of Human Amyloid Precursor Protein in Rat Cortical Neurons Inhibits Calcium Oscillations , 2009, The Journal of Neuroscience.

[16]  S. Otte,et al.  Selective α7 nicotinic acetylcholine receptor activation regulates glycogen synthase kinase3β and decreases tau phosphorylation in vivo , 2009, Brain Research.

[17]  H. Schoemaker,et al.  Inhibition of Calpain Prevents N-Methyl-d-aspartate-Induced Degeneration of the Nucleus Basalis and Associated Behavioral Dysfunction , 2008, Journal of Pharmacology and Experimental Therapeutics.

[18]  J. Waring,et al.  Role of GSK‐3β activation and α7 nAChRs in Aβ1–42‐induced tau phosphorylation in PC12 cells , 2008, Journal of neurochemistry.

[19]  O. Arancio,et al.  Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer disease. , 2008, The Journal of clinical investigation.

[20]  Ming Liu,et al.  Calpain in the CNS: From Synaptic Function to Neurotoxicity , 2008, Science Signaling.

[21]  Yu-Qiang Ding,et al.  Rapsyn Interaction with Calpain Stabilizes AChR Clusters at the Neuromuscular Junction , 2007, Neuron.

[22]  Klaus Ersfeld,et al.  The calpains: modular designs and functional diversity , 2007, Genome Biology.

[23]  Zhen Yan,et al.  Calpain regulation of AMPA receptor channels in cortical pyramidal neurons , 2007, The Journal of physiology.

[24]  Huaxi Xu,et al.  Phosphorylation of tau antagonizes apoptosis by stabilizing β-catenin, a mechanism involved in Alzheimer's neurodegeneration , 2007, Proceedings of the National Academy of Sciences.

[25]  B. Strooper,et al.  Presenilins Form ER Ca2+ Leak Channels, a Function Disrupted by Familial Alzheimer's Disease-Linked Mutations , 2006, Cell.

[26]  J. Ávila,et al.  Extracellular tau is toxic to neuronal cells , 2006, FEBS letters.

[27]  A. Wall,et al.  PET imaging of cortical 11C-nicotine binding correlates with the cognitive function of attention in Alzheimer’s disease , 2006, Psychopharmacology.

[28]  Simon C Watkins,et al.  Spatial Localization of m-Calpain to the Plasma Membrane by Phosphoinositide Biphosphate Binding during Epidermal Growth Factor Receptor-Mediated Activation , 2006, Molecular and Cellular Biology.

[29]  S. Paul,et al.  Cholinergic dysfunction in a mouse model of Alzheimer disease is reversed by an anti-A beta antibody. , 2006, The Journal of clinical investigation.

[30]  M. Costanzi,et al.  NMDA receptor mediates tau-induced neurotoxicity by calpain and ERK/MAPK activation. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Zhen Yan,et al.  Regulation of N-Methyl-D-aspartate Receptors by Calpain in Cortical Neurons* , 2005, Journal of Biological Chemistry.

[32]  J-z Wang,et al.  Microtubule-associated protein tau is a substrate of ATP/Mg2+-dependent proteasome protease system , 2005, Journal of Neural Transmission.

[33]  A. Nordberg,et al.  High selective expression of α7 nicotinic receptors on astrocytes in the brains of patients with sporadic Alzheimer's disease and patients carrying Swedish APP 670/671 mutation: a possible association with neuritic plaques , 2005, Experimental Neurology.

[34]  C. Barbato,et al.  Role of N-terminal tau domain integrity on the survival of cerebellar granule neurons , 2004, Cell Death and Differentiation.

[35]  Leslie Wilson,et al.  Differential regulation of microtubule dynamics by three- and four-repeat tau: Implications for the onset of neurodegenerative disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[36]  A. Nordberg,et al.  Correlation of oxidative stress and the loss of the nicotinic receptor alpha4 subunit in the temporal cortex of patients with Alzheimer's disease , 2003, Neuroscience Letters.

[37]  H. Tanila,et al.  Elevated levels of Aβ1–40 and Aβ1–42 do not alter the binding sites of nicotinic receptor subtypes in the brain of APPswe and PS1 double transgenic mice , 2002, Neuroscience Letters.

[38]  J. Vonsattel,et al.  Calpain activation in neurodegenerative diseases: confocal immunofluorescence study with antibodies specifically recognizing the active form of calpain 2 , 2002, Acta Neuropathologica.

[39]  D. Brunzell,et al.  Neuronal nicotinic acetylcholine receptor subunit knockout mice: physiological and behavioral phenotypes and possible clinical implications. , 2001, Pharmacology & therapeutics.

[40]  K. Wang,et al.  The calpain family and human disease. , 2001, Trends in molecular medicine.

[41]  D. Ji,et al.  Timing and Location of Nicotinic Activity Enhances or Depresses Hippocampal Synaptic Plasticity , 2001, Neuron.

[42]  E. McGowan,et al.  Survival and plasticity of basal forebrain cholinergic systems in mice transgenic for presenilin-1 and amyloid precursor protein mutant genes , 2001, Neuroreport.

[43]  A. Nordberg,et al.  Decreased Protein Levels of Nicotinic Receptor Subunits in the Hippocampus and Temporal Cortex of Patients with Alzheimer’s Disease , 2000, Journal of neurochemistry.

[44]  Z. Jia,et al.  Crystal structure of calpain reveals the structural basis for Ca2+‐dependent protease activity and a novel mode of enzyme activation , 1999, The EMBO journal.

[45]  E. Perry,et al.  α4 but Not α3 and α7 Nicotinic Acetylcholine Receptor Subunits Are Lost from the Temporal Cortex in Alzheimer's Disease , 1999 .

[46]  H. Eisenberg,et al.  Expression of nicotinic acetylcholine receptor subunits in the cerebral cortex in Alzheimer’s disease: histotopographical correlation with amyloid plaques and hyperphosphorylated‐tau protein , 1999, The European journal of neuroscience.

[47]  C. Barbato,et al.  Tau Cleavage and Dephosphorylation in Cerebellar Granule Neurons Undergoing Apoptosis , 1998, The Journal of Neuroscience.

[48]  M. Mercken,et al.  Differential sensitivity to proteolysis by brain calpain of adult human tau, fetal human tau and PHF‐tau , 1995, FEBS letters.

[49]  R. Nixon,et al.  Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[50]  D. Collerton,et al.  Cholinergic function and intellectual decline in Alzheimer's disease , 1986, Neuroscience.

[51]  H. Wiśniewski,et al.  Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. , 1986, The Journal of biological chemistry.

[52]  R. Bartus,et al.  The cholinergic hypothesis of geriatric memory dysfunction. , 1982, Science.

[53]  J. Coyle,et al.  Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. , 1982, Science.

[54]  Xin-an Liu,et al.  Tau dephosphorylation potentiates apoptosis by mechanisms involving a failed dephosphorylation/activation of Bcl-2. , 2010, Journal of Alzheimer's disease : JAD.

[55]  Jian-Zhi Wang,et al.  Tau overexpression inhibits cell apoptosis with the mechanisms involving multiple viability-related factors. , 2010, Journal of Alzheimer's disease : JAD.

[56]  Q. Tian,et al.  Overexpression of tau proteins antagonizes amyloid-beta-potentiated apoptosis through mitochondria-caspase-3 pathway in N2a cells. , 2010, Journal of Alzheimer's disease : JAD.

[57]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[58]  E. Perry,et al.  Alpha4 but not alpha3 and alpha7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease. , 1999, Journal of neurochemistry.

[59]  G. Glenner,et al.  Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. , 1984, Biochemical and biophysical research communications.